Search Results 211-220 of 38842 for Two-phase
The purpose of this study is to determine the optimal biologic dose (OBD) and recommended Phase 2 dose (RP2D) of BMF-219 monotherapy (Cohorts 1, 2, 3, and 4).
This is a Phase 2, open-label, single arm study to evaluate the safety and efficacy of niraparib in ovarian cancer patients who have received three or four ...
The objectives and endpoints are identical for Stage 1 (recurrent CDI) and Stage 2 (high-risk primary CDI). Only adults will be enrolled at Mayo Clinic Arizona ...
The Stage 2 portion will enroll up to 18 patients with each of the 4 myeloproliferative malignancies: SM, PED, MF, and CMML. ... A Phase 2, Multi-center, Open- ...
The objectives and endpoints are identical for Stage 1 (recurrent CDI) and Stage 2 (high-risk primary CDI). Participation eligibility. Participant eligibility ...
... Phase, which focuses on establishing foundational medical knowledge. ... Dedicated study time is provided during the final six months of year two to prepare for ...
Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...
Certain blood pressure medicines. Taking an angiotensin-converting enzyme (ACE) inhibitor or an angiotensin 2 receptor blocker (ARB) has been shown to protect ...
The purpose of this study is to evaluate the safety and tolerability and determine the recommended Phase 2 dose (RP2D) of YH001 when given with envafolimab ...
This phase II trial studies how well alisertib ... The main purpose of this study is to evaluate the safety and efficacy of two ... The present study is an open- ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.